FIELD: medicine.
SUBSTANCE: invention relates to application of antisecretory protein (AF) or homologue and/or its fragment, which has antisecretary activity, and/or its pharmaceutically active salt, where said protein (AP) corresponds to amino acid sequence, presented in SEQ ID NO:6 and/or where said fragment contains amino acid sequence, presented in SEQ ID N:4 for preparation of pharmaceutical composition or medicinal product for treatment or prevention of compartment-syndrome.
EFFECT: invention ensures elimination or reduces development of increased pressure in closed compartments, which facilitates introduction of other pharmaceutical medications, as well as aiming of said medications medicines at their target.
39 cl, 14 ex, 6 dwg
Title | Year | Author | Number |
---|---|---|---|
LIPID RAFT MODULATION | 2007 |
|
RU2457853C2 |
NEW APPLICATION | 2004 |
|
RU2416426C2 |
LOCAL APPLICATION OF HSV ANTIBODY | 2015 |
|
RU2703903C2 |
METHOD FOR PRODUCTION OF EGG YOLK WITH HIGH CONTENT OF AF-16 | 2016 |
|
RU2723097C1 |
NEW THERAPEUTIC APPROACH TO INTRAOCULAR PRESSURE INCREASE | 2007 |
|
RU2458703C2 |
ADENO-ASSOCIATED VIRUS VECTOR | 2015 |
|
RU2743382C2 |
CURTAILED SECRETABLE ASPARTYL-PROTEINASE 2 | 2008 |
|
RU2493255C2 |
MODIFIED INTERLEUKIN-7 PROTEIN AND METHODS FOR USE THEREOF | 2016 |
|
RU2708160C2 |
FUSED POLYPEPTIDES AND VACCINES | 2014 |
|
RU2699006C2 |
COMPOSITIONS AND METHODS, APPLIED FOR ACCELERATION OF WOUND HEALING AND TISSUE REGENERATION | 2005 |
|
RU2438696C2 |
Authors
Dates
2012-11-10—Published
2007-04-27—Filed